Home | AI powered stock trade ideas | Market Signals | Breaking Out | New Green Signal Stocks | Recent Red Arrow Top Signals | Recent Green Arrow Bottom Signals | Near Term Bottom Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

Recently Featured Stock Charts
86% AI Stock Prediction Accuracy
Enter Stock Symbol to View AI powered Stock Chart


All Chart Prices as of Previous Day Close

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.

Last Price: 82.94 - Change: -0.95 - Change %: -1.1324
04/17/2024 16:00:00 EST

Bruker Corporation (BRKR)

Industry: Medical Devices

Price Support Resistance

In the past 20 trading days, BRKR has been trading in a range between $94.27 and $87.58 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

The AI powered stock chart is in a Red zone currently. We would avoid this stock.

Upside / Downside Potential

Bruker Corporation $BRKR entered a Red zone 4 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $77.78, a potential down side of -6.22% from the recent price of 82.94. Our AI powered stock target predictor currently has a target price of $100.64 a potential move of 21%. The stock is trading 14.37% (potential upside) below its 52 week high of $94.86 and 54.39 % (potential downside) above its 52 week low of $53.72 - based on the recent price.

Company Summary

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.

BRKR Website


Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process
NanoString announced Wednesday that it will be acquired by Bruker, ending the company's restructuring process that included a Chapter 11 bankruptcy plan.
Source: GeekWire
Wed, 17 Apr 2024 21:05:55 -0400
Sentiment: Positive
Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research
Life science tool companies have faced challenges in the post-pandemic adjustment process, but Bruker has fared better than many due to its leverage to research tools. Bruker's high exposure to potentially weaker academic and government end-markets presents challenges, but Bruker's tools address high-priority research areas in biology, pharmaceuticals, and semiconductors. Bruker is well-positioned for healthy revenue growth in 2024, with potential growth in the Chinese market and increasing interest in proteomics and spatial biology driving growth opportunities.
Source: Seeking Alpha
Thu, 11 Apr 2024 16:43:08 -0400
Sentiment: Positive
Bruker (BRKR) Introduces Magnet Technology for NMR Adoption
Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.
Source: Zacks Investment Research
Tue, 09 Apr 2024 10:06:20 -0400
Sentiment: Neutral
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
ASILOMAR, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific capabilities that can enable unprecedented structural biology discoveries in large proteins, membrane proteins and in protein aggregates. At the 65th ENC (www.enc-conference.org), Bruker introduces a new ultra-fast CP/MAS iProbe as the latest innovation in solid-state.
Source: Business Wire
Mon, 08 Apr 2024 07:00:00 -0400
Sentiment: Neutral
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
ASILOMAR, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies (PAT). At the 65th ENC (www.enc-conference.org), Bruker introduces the Ascend Evo 600, a novel compact 54 mm standard-bore 14.1 Tesla (6.
Source: Business Wire
Mon, 08 Apr 2024 07:00:00 -0400
Sentiment: Neutral
Instituions Institution %: 81.824
Last QTR Institution change: -182511

Insiders %: 34.66
Insiders Purchases last QTR: 0
Insiders Sales last QTR: 403667
Insiders Net last QTR: -403667

Analyst Ratings
Target Price: 77.78
Overall Rating: 4.0909
Strong Buys (5): 6
Buys (4): 1
Holds (3): 3
Sells (2): 1
Strong Sells (1): 0

52 Week Hi: 94.86
52 Week Low: 53.7176
Beta: 1.18
50 Day MA: 86.6376
200 Day MA: 71.6358

Earnings / Revenue Trends
Qtr Earnings Growth YOY: 1.127
Qtr Revenue Growth YOY: 0.206
Forward PE: 31.9489
Trailing PE: 28.9276

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!


Stock Analyzed Each Night


Easily Upload Track Your Stocks


See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.